Product Program year 2022 Source: CMS Open Payments

Ezallor Sprinkle

Drug Cardiology Vascular Diseases

NDC 47335-984-64

Open in the dashboard

General payments

$130,504

2,270 payments

Research payments

$0

0 payments

Through program year 2022, $130,504 in general payments and $0 in research payments were reported against Ezallor Sprinkle (Cardiology Vascular Diseases).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2022 General $9,239 142
2021 General $121,266 2,128

Breakdown

Who paid General payments · program years 2021–2022
  1. Sun Pharmaceutical Industries Inc. $130,504 2,270 payments
Top recipients General payments · program year 2022
  1. Albert Riddle Geriatric Medicine · Haworth, NJ $4,000 43% · 4 payments
  2. Christopher Chappel Family Medicine · Kissimmee, FL $1,750 19% · 1 payment
  3. Mary Parker Nurse Practitioner, Gerontology · Fort Wayne, IN $700 8% · 1 payment
  4. Mashhoordin Rajudin Rajudin Nephrology · Anaheim, CA $121 1% · 1 payment
  5. Jamie Freelin Internal Medicine · Greenville, SC $54 <1% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2022.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2022
  1. Geriatric Medicine Internal Medicine $4,035 44% · 3 practitioners
  2. Family Medicine $2,336 25% · 29 practitioners
  3. Nurse Practitioner, Gerontology Nurse Practitioner $791 9% · 4 practitioners
  4. Internal Medicine $719 8% · 35 practitioners
  5. Nurse Practitioner, Family Nurse Practitioner $422 5% · 20 practitioners

The top 5 of 19 specialties; each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2022
  1. New York $4,103 44% · 8 recipients
  2. Florida $1,832 20% · 5 recipients
  3. California $965 10% · 39 recipients
  4. Indiana $799 9% · 6 recipients
  5. North Carolina $410 4% · 16 recipients

The top 5 of 18 states; each share is of general payments naming this product in 2022 where a state was reported.

The top 25 states, free in the app

2,270 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record